1Munoz, M, Dumas, M, Boutros-Toni, F et al. Prevalence of headache in a representative sample of the population in a French department (Haute-Vienne-Limousin). Headache 1993; 33: 521–23.CrossRefGoogle Scholar

2Cook, NR, Evans, DA, Funkenstein, HH et al. Correlates of headache in a population-based cohort of elderly. Arch Neurol 1989; 46: 1338–44.CrossRefGoogle Scholar

3Stewart, WF, Lipton, RB, Celentano, DD, Reed, ML. Prevalence of migraine headache in the United States. Relation to age, income, race and other sociodemographic factors. JAMA 1992; 267: 64–69.CrossRefGoogle ScholarPubMed

4Zeigler, ZK, Hassanein, RS, Couch, JR. Characteristics of life headache histories in a non-clinical population. Neurology 1977; 27: 265–69.CrossRefGoogle Scholar

5 Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgia and facial pain. Cephalalgia 1988; 8: (suppl 7): 9–46.Google Scholar

6Rasmussen, BK, Olesen, J. Epidemiology of migraine and tension-type headache. Curr Opin Neurol 1994; 7: 264–71.CrossRefGoogle ScholarPubMed

7Hale, WE, May, FE, Marks, RG, Moore, MT, Stewart, RB. Headache in the elderly: an evaluation of risk factors. Headache 1987; 27: 272–78.CrossRefGoogle ScholarPubMed

8Hauser, WA, Ferguson, RH, Holley, KE, Kurland, LT. Temporal arteritis in Rochester, Minnesota, 1951–1967. Mayo Clin Proc 1971; 46: 597–602.Google Scholar

9Lance, JW. Mechanisms and management of headache, fifth edition. Cambridge: Butterworth-Heinemann, 1993.Google Scholar

10Solomon, S, Cappa, KG. The headache of temporal arteritis. Am Geriatr Soc 1987; 35: 163–65.CrossRefGoogle ScholarPubMed

11Bunch, TW. Giant cell (temporal) arteritis. In: Kelley, WN ed. Textbook of internal medicine, second edition. Philadelphia: Lippincott, 1992: 960.Google Scholar

12Goodman, BW. Temporal arteritis. Am J Med 1979; 67: 839–52.CrossRefGoogle ScholarPubMed

13Koorey, DJ. Cranial arteritis. A twenty-year review of roses. Aust N Z J Med 1984; 14: 143–47.CrossRefGoogle Scholar

14Lipton, RB, Solomon, S, Wertenbaker, C. Gradual loss and recovery of vision in temporal arteritis. Arch Int Med 1985; 145: 2252–53.CrossRefGoogle ScholarPubMed

15Wong, RL, Korn, JH. Temporal arteritis without an elevated erythrocyte sedimentation rate: case report and review of the literature. Am J Med 1986; 80: 959–64.CrossRefGoogle ScholarPubMed

16Klein, RG, Campbell, RJ, Hunder, CT et al. Skip lesions in temporal arteritis. Mayo Clin Proc 1976; 51: 504–10.Google ScholarPubMed

17Kyle, V, Hazelman, BL. Stopping steroids in polymyalgia rheumatica and giant cell arteritis. BMJ 1990; 300: 344–45.CrossRefGoogle ScholarPubMed

18Caselli, RJ, Hunder, GG, Whisnant, JP. Neurologic disease in biopsy-proven giant cell (temporal) arteritis. Neurology 1988; 38: 352–59.CrossRefGoogle ScholarPubMed

19Graham, E, Holland, A, Avery, A, Ross, Russell RW. Prognosis in giant cell arteritis. BMJ 1981; 282: 209–71.CrossRefGoogle ScholarPubMed

20Kyle, V, Hazelman, BL. The clinical and laboratory course of polymyalgia rheumatica/giant cell arteritis. Br J Rheumatol 1988; 27 (suppl 1): 7.Google Scholar

21Ayoob, WT, Franklin, CM, Torretti, D. Polymyalgia rheumatica. Duration of therapy and outcome. Am J Med 1985; 79: 309–15.CrossRefGoogle Scholar

22Portenoy, RK, Abissi, CJ, Lipton, RB et al. Headache in cerebrovascular disease. Stroke 1984; 15: 1009–12.CrossRefGoogle ScholarPubMed

23Ostergaard, JR. Headache as a warning symptom of impending aneurysmal subarachnoid haemorrhage. Cephalalgia 1991; 11: 53–55.CrossRefGoogle ScholarPubMed

24Cameron, MM. Chronic subdural haematoma: a review of 114 cases. J Neural Neurosurg Psychiatry 1978; 41: 834–39.CrossRefGoogle ScholarPubMed

25Iversen, MK, Strange, P, Sommer, W, Tjalve, E. Brain tumour headache related to tumour size, histology and location. Cephalalgia 1987; 7 (suppl 6): 394–95.CrossRefGoogle Scholar

26Godfrey, JD, Caird, FI. Intracranial tumours in the elderly. Diagnosis and treatment. Age Ageing 1984; 13: 152–58.CrossRefGoogle ScholarPubMed

27Rando, TA, Rishman, RA. Spontaneous intracranial hypotension: report of two cases and review of the literature. Neurology 1992; 42: 481–87.CrossRefGoogle ScholarPubMed

28O'Neill, P. Cranio-cerebral trauma. In: Tallis, R ed. The clinical neurology of old age. Chichester: Wiley, 1989: 285–96.Google Scholar

29Gilbey, SJ, Ramadan, NM, Aurora, TK, Schultz, LR, Welch, KMA. Cerebral blood flow is abnormal in post-traumatic headache. In: Rose, FC ed. New advances in headache research: 4. London: Smith-Gordon, 1994: 59–60.Google Scholar

30Sjaastad, O. Cervicogenic headache: the controversial headache. Clin Neural Neurosurg 1992; 94: (suppl): 5147–49.Google ScholarPubMed

31Bovim, G, Sand, T. Cervicogenic headache, migraine without aura and tension type headache. Diagnostic blockage of greater occipital and supra-orbital nerves. Pain 1992; 51: 43–48.CrossRefGoogle Scholar

32Joseph, D, Renner, G. Head pain from diseases of the ear, nose and throat. Neural Clin 1983; 1: 399–414.CrossRefGoogle Scholar

33Tomsak, R. Ophthalmologic aspects of headache. Med Clin North Am 1991; 75: 693–706.CrossRefGoogle ScholarPubMed

34Indo, T, Naita, A, Sobue, I. Clinical characteristics of headache in Parkinson's Disease. Headache 1983; 23: 211–12.CrossRefGoogle ScholarPubMed

35Indaco, A, Carrier, PB. Amitriptyline in the treatment of headache in patients with Parkinson's Disease: a double blind placebo controlled study. Neurology 1988; 38: 1720–22.CrossRefGoogle ScholarPubMed

36Askmark, H, Lundberg, PO, Olson, S. Drug related headaches. Headache 1989; 29: 441–44.CrossRefGoogle Scholar

37Fromm, GH, Graff-Radford, SB, Terrence, CF, Sweet, WH. Pre-trigeminal neuralgia. Neurology 1990; 40: 1493–95.CrossRefGoogle ScholarPubMed

38Selby, G. Diseases of the fifth cranial nerve. In: Dyck, PH, Thomas, PK, Lambert, EH eds. Peripheral neuropathy. Philadelphia: Saunders, 1975: 533–69.Google Scholar

39Katusic, S, Beard, CM, Bergstralh, E, Kurland, LT. The incidence and clinical features of trigeminal neuralgia. Rochester, Minnesota, 1945–1984. Ann Neural 1990; 27: 89–95.CrossRefGoogle ScholarPubMed

40Fromm, GH, Terrence, CF, Maroon, JC. Trigeminal neuralgia. Current concepts regarding etiology and pathogenesis. Arch Neural 1984; 41: 1204–207.CrossRefGoogle ScholarPubMed

41Tomson, T, Ekbom, K. Trigeminal neuralgia: time course of pain in relation to carbamazepine dosing. Cephalalgia 1981; 1: 91–97.CrossRefGoogle ScholarPubMed

42Umino, M, Ohwatari, T, Shimoyama, K, Nagao, M. Long-term observation of the relation between pain intensity and serum carbamazepine concentration in elderly patients with trigeminal neuralgia. J Oral Maxillofac Surg 1993; 51: 1338–44.CrossRefGoogle ScholarPubMed

43Fromm, GH, Terrence, CF, Chatta, S. Baclofen in the treatment of trigeminal neuralgia; double blind study and long-term follow-up. Ann Neural 1984; 15: 240–44.CrossRefGoogle ScholarPubMed

44Fromm, GH, Terrence, CF. Comparison of L-baclofen and racemic baclofen in trigeminal neuralgia. Neurology 1987; 37: 1725–28.CrossRefGoogle ScholarPubMed

45Dalessio, D. Diagnosis and treatment of cranial neuralgias. Med Clin North Am 1991; 75: 605–15.CrossRefGoogle ScholarPubMed

46Steiger, HJ. Prognostic factors in the treatment of trigeminal neuralgia. Analysis of differential therapeutic approach. Acta Neurochirugica 1991; 113: 11–17.CrossRefGoogle ScholarPubMed

47Demoragas, JM, Kierland, RR. The outcome of patients with herpes zoster. Arch Dermatol 1957; 75: 193–96.CrossRefGoogle Scholar

48Watson, CPN. Postherpetic neuralgia: clinical features and treatment. In: Fields, HL ed. Pain syndromes in neurology. London: Butterworths, 1990: 223–38.CrossRefGoogle Scholar

49Esmann, V, Geil, JP, Kroon, S et al. Prednisolone does not prevent postherpetic neuralgia. Lancet 1987; ii: 126–29.CrossRefGoogle Scholar

50 Post-herpetic neuralgia [Editorial]. Lancet 1990; 336: 537–38.CrossRefGoogle Scholar

51Max, MB, Schafer, SC, Culnane, M, Smoller, B, Dubner, R, Gracely, RH. Amitriptyline, but not loracepam, relieves postherpetic neuralgia. Neurology 1988; 38: 1427–32.CrossRefGoogle Scholar

52Watson, CP, Evans, RJ, Reed, K, Merskey, H, Goldsmith, L, Warsh, J. Amitriptyline vs. placebo in postherpetic neuralgia. Neurology 1982; 32: 671–73.CrossRefGoogle Scholar

53Jessell, TM, Iversen, LL, Cuello, AC. Capsaicin-induced depletion of substance P from primary sensory neurons. Brain Res 1979; 152: 132–88.Google Scholar

54Bates, JA, Nathan, PW. Transcutaneous nerve stimulation for chronic pain. Anaesthesia 1980; 35: 817–23.CrossRefGoogle ScholarPubMed

55Mathew, NT. Chronic refractory headache. Neurology 1993; 43 (suppl 3): 526–33.Google ScholarPubMed

56Solomon, G, Kunkel, R, Frame, J. Demographics of headache in elderly patients. Headache 1990; 30: 273–76.CrossRefGoogle ScholarPubMed

57Langemark, M, Olsen, J, Poulsen, DL, Beck, P. Clinical characterisation of patients with chronic tension headaches. Headache 1988; 28: 590–96.CrossRefGoogle Scholar

58Mathew, NT, Stubits, E, Nigam, M. Transformation of migraine into daily headache: analysis of factors. Headache 1982; 22: 66–68.CrossRefGoogle ScholarPubMed

59Diaz-Mitoma, F, Vanast, WJ, Tyrell, DLJ. Increased frequency of Epstein-Barr Virus excretion in patients with new daily persistent headaches. Lancet 1987; ii: 411–15.CrossRefGoogle Scholar

60Diamond, S. Treatment of chronic headaches: a non-pharmacological approach. In: Rose, FC ed. New advances in headache research: 4. London: Smith-Gordon, 1994: 197–204.Google Scholar

61Diener, HC, Haab, J, Peters, C, Reid, S, Dichgans, J, Pilgrim, A. Subcutaneous sumatriptan in the treatment of headache during withdrawal from drug-induced headache. Headache 1991; 31: 205–209.CrossRefGoogle ScholarPubMed

62Mathew, NT, Ali, S. Valproate in the treatment of persistent chronic daily headache. An open label study. Headache 1991; 31: 71–74.CrossRefGoogle ScholarPubMed

63Raskin, NR. Headache, second edition. New York: Churchill Livingstone, 1988.Google ScholarPubMed

64Merikangas, KR, Tierney, C, Martin, NG, Heath, AC. Genetics of migraine in the Australian Twin Registry. In: Rose, FC ed. New advances in headache research: 4. London: Smith-Gordon, 1994: 27.Google Scholar

65Blau, JN. Migraine prodromes separated from the aura: complete migraine. BMJ 1980; 281: 658–60.CrossRefGoogle ScholarPubMed

66Morrison, DP. Abnormal perceptual experiences in migraine. Cephalalgia 1990; 10: 273–77.CrossRefGoogle ScholarPubMed

67Blau, JN. Adult migraine: the patient observed. In: Blau, JN ed. Migraine: clinical and research aspects. Baltimore: Johns Hopkins University Press, 1987: 3–30.Google Scholar

68Baumel, B, Eisner, LS. Diagnosis and treatment of headache in the elderly. Med Clin North Am 1991; 75: 661–75.CrossRefGoogle ScholarPubMed

69Mathew, NT. Drug induced headache. Neural Clin 1990; 8: 908–12.Google ScholarPubMed

70Edmeads, J. Migraine equivalents and complicated migraine. Med Clin North Am 1991; 75: 567–77.CrossRefGoogle ScholarPubMed

71Kudrow, L. The relationship of headache frequency to hormone use in migraine. Headache 1975; 15: 36–40.CrossRefGoogle ScholarPubMed

72Ross-Lee, LM, Eadie, MJ, Heazlewood, V, Bochner, F, Tyrer, JH. Aspirin pharmacokinetics in migraine: the effect of metaclopramide. Eur J Clin Pharmacol 1983; 24: 777–85.CrossRefGoogle Scholar

73The Sumatriptan Auto-injector Study Group. Self treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device. Eur Neural 1991; 31: 323–31.CrossRefGoogle Scholar

74Pearce, JMS. Sumatriptan: efficacy and contribution to migraine mechanisms. J Neural Neurosurg Psychiatry 1992; 55: 1103–106.CrossRefGoogle ScholarPubMed

75Gobel, H, Ribbat, M, May, A et al. Long-term efficacy and tolerability of s. c. supatriptan; a nationwide multicentre study. In: Rose, FC ed. New advances in headache research: 4. London: Smith-Gordon, 1994: 189–94.Google Scholar

76Bates, D. Treatment with subcutaneous sumatriptan during migraine aura. Cephalalgia 1993; 13 (suppl 13): 188.Google Scholar

77Ottervanger, JP, Poalman, HJA, Boxma, GL, Strieker, BHC. Transmural myocardial infarction with sumatriptan. Lancet 1993; 341: 861–62.CrossRefGoogle ScholarPubMed

78Pradalier, A, Rancurel, G, Dourdain, G, Verdure, L, Rascol, A, Dry, JH. Acute migraine attack therapy; comparison of naproxen sodium and an ergotamine tartrate compound. Cephalalgia 1985; 5: 107–13.CrossRefGoogle Scholar

79Harvey, PR, Spiers, DR, Wood, DA. A comparison of bisoprolol with propranolol in the prophylaxis of common or classic migraine – a randomised, double-blind, crossover, multicentre trial in the United Kingdom. In: Rose, FC ed. New advances in headache research: 4. London: Smith-Gordon, 1994: 133–40.Google Scholar

80Couch, JR, Hassanein, RS. Amitriptyline in migraine prophylaxis. Arch Neural 1979; 36: 695–99.CrossRefGoogle ScholarPubMed

81Clough, CG. Treating migraine. BMJ 1989; 299: 141–42.CrossRefGoogle ScholarPubMed

82Amery, WK. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine. Headache 1983; 23: 70–74.CrossRefGoogle ScholarPubMed

83Ghose, K. Long term Valproate therapy in drug-resistant migraine. In: Rose, FC ed. New advances in headache research: 4. London: Smith-Gordon, 1994: 149.Google Scholar

84Russell, MB, Andersson, PG, Thomsen, LL. Familial occurrence of cluster headache. In: Rose, FC ed. New advances in headache research: 4. Cambridge: Smith-Gordon, 1994: 209–10.Google Scholar

85Drummond, PD. Autonomie disturbance in cluster headache. Brain 1988; 111: 1199–209.CrossRefGoogle Scholar

86Kudrow, L. Cluster headache: mechanisms and management. London: Oxford University Press, 1980.Google Scholar

87Fisher, CM. The headache and pain of spontaneous carotid dissection. Headache 1982; 22: 60–65.CrossRefGoogle ScholarPubMed

88Kudrow, L. Response of cluster headache to oxygen inhalation. Headache 1981; 21: 1–4.CrossRefGoogle ScholarPubMed

89Pearce, JNS. Headache. J Neural Neurosurg Psychiatry 1994; 57: 134–43.CrossRefGoogle ScholarPubMed

90The Sumatriptan Cluster Headache Study Group. Treatment of acute cluster headaches with sumatriptan. N Engl J Med 1991; 325: 322–26.CrossRefGoogle Scholar

91Solomon, S, Lipton, RB, Newman, LC. Prophylactic therapy of cluster headaches. Clin Neuropharmacol 1991; 14: 116–30.CrossRefGoogle ScholarPubMed

92Hering, R, Kuritzky, A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989; 9: 195–98.CrossRefGoogle ScholarPubMed

93Antonaci, F, Sjaastad, O. Chronic paroxysmal hemicrania (CPH): a review of the clinical manifestations. Headache 1989; 29: 648–56.CrossRefGoogle ScholarPubMed

94Newman, LC, Lipton, RB, Solomon, S. The hypnic headache syndrome. Neurology 1990; 40: 1904–905.CrossRefGoogle ScholarPubMed

95Raskin, MN. The hypnic headache syndrome. Headache 1988; 28: 534–36.CrossRefGoogle ScholarPubMed

96Pearce, JMS. Exploding head syndrome. Lancet 1988; ii: 270–71.CrossRefGoogle Scholar

97Gordon, AG. Exploding head [letter]. Lancet 1988; ii: 625–26.Google Scholar

98Pearce, JMS. Clinical features of the exploding head syndrome. J Neural Neurosurg Psychiatry 1989; 52: 907–10.CrossRefGoogle ScholarPubMed